Table 1

Antibacterial resistance of MRSA isolates, 1994–2004.
Year
 Antibacterial resistance in MRSA (%)


#
 Gm
 Km
 Sm
 Em
 Cm
 Tet
 Tp
 Cip
 Fa
 Rf
 MupH
 Cd*
1994
 342
 98
 100
 100
 66
 25
 94
 86
 53
 22
 1.0
 ND
 100
1995
 298
 95
 98
 100
 89
 25
 92
 87
 23
 45
 1.4
 ND
 98
1996
 421
 100
 100
 100
 68
 44
 94
 93
 41
 32
 3.0
 6.0
 100
1997
 245
 94
 99
 99
 81
 23
 95
 75
 72
 57
 5.0
 17
 97
1998
 329
 88
 95
 77
 74
 21
 92
 61
 63
 75
 3.0
 24
 94
1999
 336
 84
 92
 92
 69
 4.0
 93
 38
 79
 89
 2.0
 28
 94
2000
 542
 86
 95
 94
 76
 3.0
 89
 34
 72
 81
 8.0
 22
 98
2001
 533
 77
 88
 89
 86
 2.0
 79
 37
 81
 88
 1.0
 2.7
 94
2002
 883
 85
 95
 89
 88
 4.0
 90
 16
 96
 90
 5.0
 3.0
 93
2003
 785
 77
 88
 89
 86
 4.0
 88
 17
 88
 85
 1.0
 1.0
 91
2004
 930
 81
 89
 86
 88
 2.0
 88
 27
 92
 92
 4.7
 4.7
 89

Abbreviations: #, number of isolates Gm, gentamicin, Km, kanamycin, Sm, streptomycin, Em, erythromycin, Cm, chloramphenicol, Tet, tetracycline, Tp, trimethoprim, Cip, ciprofloxacin, Fa, fusidic acid, Rf, rifampicin, MupH, high-level mupirocin resistance, Cd, cadmium acetate, also resistant to mercuric chloride, propamidine isethionate and ethidium bromide, ND, not detected

Udo et al. BMC Infectious Diseases 2006 6:168   doi:10.1186/1471-2334-6-168